See also this year's filing and all EDGAR filings for this company.
PDF Report 0001053369_2020_Elite_Pharmaceuticals_INC_NV.pdf
Logs
Graph
Absolute values for 0001053369, Elite Pharmaceuticals INC NV
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 8,856,542 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,634,035 |
| 2 | PropertyPlantAndEquipmentNet | 8,443,849 |
| 3 | remainder_Assets | 467,508 |
| 4 | LiabilitiesCurrent | 6,906,132 |
| 5 | LiabilitiesNoncurrent | 6,099,706 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 7,370,550 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,136,358 |
| 9 | ResearchAndDevelopmentExpense | 5,564,423 |
| 10 | remainder_Expenses | 493,356 |
| 11 | remainder_Revenues | 9,856,402 |
| 12 | remainder_NetIncome | 7,744,784 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 24,401,934 |
| 1 | Liabilities | 13,005,838 |
| 2 | Expenses | 16,564,687 |
| 3 | Revenues | 9,856,402 |
| 4 | StockholdersEquity | 11,396,096 |
| 5 | NetIncome | 1,036,499 |
| 6 | ComprehensiveNetIncome | 1,036,499 |
| 7 | BaseVar | 35,786,822 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.38 |
| 9 | EconomicCapitalRatio | 2.59 |
Edgar->Model Mapping
Feature Distribution
Change over Time
